Xeris Biopharma Holdings Inc. (NASDAQ:XERS) Stock Moves Up After Results From the Logics Study of Recorlev®

May 13, 2022

The premarket action often provides investors and traders with a glimpse into the possibilities during the coming trading day and by that token, it could be a good move to perhaps take a look at the Xeris Biopharma Holdings Inc. (NASDAQ:XERS) stock. Trading Data On Thursday, XERS stock fell 7.32% to $1.52 with 6.24 million shares, compared to its average volume of 1.60 million shares. The stock moved within a…

Read More >>